Key result
Microbiome therapies emerge as promising strategies to enhance ischemic stroke recovery.
Answers are grounded in this paper and cite their sources.
This review highlights the critical role of the gut-brain axis in ischemic stroke and identifies microbiome-targeted therapies and dietary management as promising avenues for treatment and recovery.
Ischemic stroke (IS) is a cerebrovascular disease that predominantly affects middle-aged and elderly populations, exhibiting high mortality and disability rates. At present, the incidence of IS is increasing annually, with a notable trend towards younger affected individuals. Recent discoveries concerning the “gut-brain axis” have established a connection between the gut and the brain. Numerous studies have revealed that intestinal microbes play a crucial role in the onset, progression, and outcomes of IS. They are involved in the entire pathophysiological process of IS through mechanisms such as chronic inflammation, neural regulation, and metabolic processes. Although numerous studies have explored the relationship between IS and intestinal microbiota, comprehensive analyses of specific microbiota is relatively scarce. Therefore, this paper provides an overview of the typical changes in gut microbiota following IS and investigates the role of specific microorganisms in this context. Additionally, it presents a comprehensive analysis of post-stroke microbiological therapy and the relationship between IS and diet. The aim is to identify potential microbial targets for therapeutic intervention, as well as to highlight the benefits of microbiological therapies and the significance of dietary management. Overall, this paper seeks to provide key strategies for the treatment and management of IS, advocating for healthy diets and health programs for individuals. Meanwhile, it may offer a new perspective on the future interdisciplinary development of neurology, microbiology and nutrition. • The gut microbiota is closely associated with ischemic stroke, highlighting the significance of the brain-gut-microbiota axis. • Common alterations in gut microbial composition following ischemic stroke include Lactobacillus, Bifidobacterium, Prevotella, Akkermansia muciniphila, and Escherichia coli, each playing distinct roles in post-stroke recovery. • The potential of microbiome therapy, including probiotics and fecal microbiota transplantation, is emerging as a promising strategy for enhancing recovery. • Dietary factors significantly influence gut microbiota during stroke, suggesting that dietary regulation may be a crucial component of stroke management. • New perspectives in gut microbiota research are focusing on the study of gut microbiome epigenetic modifications, the development of engineered probiotics, and interdisciplinary collaborative development.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) conducted a review in Ischemic stroke. Gut microbiota and microbiological therapy was evaluated. Gut microbiota is closely associated with ischemic stroke, and microbiome therapies like probiotics and fecal microbiota transplantation are emerging as promising strategies for enhancing recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: